Boval BioSolutions and Biophyll Announce European Distribution Agreement
Posted by Jalea D. Starnes

For Immediate Release 
Boval BioSolutions, LLC and Biophyll GmbH, have announced an agreement to stock and distribute Boval biological products in Europe through a network of distributors. Texas based Boval manufactures high purity bovine serum albumin and human serum albumin products for cell culture media and diagnostic reagents. Biophyll GmbH, a German company specializing in the financing and importation of biological raw materials, has over 20 years of experience on the cell culture market. Biophyll’s long history with biologics and biological companies allows them to have strong connections with leading distributors of high quality supplies to the bio-pharmaceutical industry in Europe. The agreement will allow current and future Boval customers to have immediate access to Boval albumin by having the products stocked and stored in their country of location.

Due to the complex nature of European regulations Boval and Biophyll are working with M bioserviceS, experts in worldwide biological sourcing, logistics and regulatory compliance. Terms of the agreement are confidential. 
Biophyll’s President Dr. Peter Haeusl states, “having ready access to Boval’s BSA and HSA formulations in Europe allows us ensure the availability of biological raw materials in an ever-changing European regulatory environment.”

Boval Company President Cody Yarborough commented “Europe has always been an important market for our biological products and working with Biophyll to have our products stocked in Europe provides a strategic avenue to ensure our customers are never without their critical raw materials.”

Questions concerning the agreement should be directed toward Mr. Yarborough in the US whose contact information can be found at or Mr. Haeusl in Germany, who can be reached at Queries regarding European importation regulations and worldwide animal by-product logistics can be addressed to Mrs. Maria Seriakov at


Be the first to leave a comment...